Literature DB >> 20049430

Usefulness of percutaneous biopsy in diagnosing benign renal masses that mimic malignancy.

V Anik Sahni1, Amy Ly, Stuart G Silverman.   

Abstract

Percutaneous biopsy has long been used to diagnose malignancies of the kidney. It is an established technique with multiple indications. Percutaneous biopsy now can be used to diagnose benign conditions that may mimic a malignancy and lead to unnecessary treatments. Advances in cytological techniques such as immunocytochemistry and cytogenetics have allowed for an increased diagnostic yield. In this review, various benign entities that may present as a renal mass are discussed and the vital role of percutaneous biopsy detailed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20049430     DOI: 10.1007/s00261-009-9597-5

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  5 in total

1.  Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.

Authors:  Amjad Shalabi; Zaid Abassi; Hoda Awad; Sarel Halachmi; Boaz Moskovitz; Yoram Kluger; Ofer Nativ
Journal:  World J Urol       Date:  2013-02-22       Impact factor: 4.226

2.  Renal angiomyoadenomatous tumour: Imaging features.

Authors:  V Anik Sahni; Michelle S Hirsch; Stuart G Silverman
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

Review 3.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04

4.  Mucinous tubular and spindle cell carcinoma of the kidney: imaging features.

Authors:  V Anik Sahni; Michelle S Hirsch; Cheryl A Sadow; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2012-03-05       Impact factor: 3.909

Review 5.  Heterogeneity and renal mass biopsy: a review of its role and reliability.

Authors:  Jeffrey J Tomaszewski; Robert G Uzzo; Marc C Smaldone
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.